Healthcare Professionals
Sprint Quattro
Implantable Cardioverter Defibrillator (ICD) Leads
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Healthcare Professionals
Implantable Cardioverter Defibrillator (ICD) Leads
Proven performance didn’t happen by chance.
From lead design to active product monitoring, intentional choices and proactive steps were taken to ensure the reliability of the Sprint Quattro family of leads.
Now with MRI access
Sprint Quattro Secure models 6947M and the 6935M defibrillator leads are approved for use in the MR environment. A complete SureScan™ defibrillation system is required for use in the MR environment, which includes a Medtronic SureScan device connected to Medtronic SureScan Leads.
Let us show you Why Quattro.
Proven by Active Monitoring
Sprint Quattro® has 11 years of proven performance and the most extensive in vivo experience in the market.
Surgical complications, such as cardiac perforation, may occur and care must be taken when placing and positioning a cardiac lead.
Years of Active In Vivo Data Reported by Manufacturer in Product Performance Report. Data as of November 2, 2015.
St. Jude Medical Product Performance Report, May 2012.
Boston Scientific Product Performance Report 2012, Q3.
Tim Samsel, VP of CRDM Quality and Regulatory
Tim discusses the active monitoring of the Sprint Quattro via
the SLS, the largest clinical study of its kind.
View Video: Medtronic’s System Longevity Study (SLS) Explained (1:01, 4.8 MB)
Sprint Quattro Secure® 6947 lead shows a 95% lead survival rate at 11 years when measured by this active monitoring1:
IMPORTANT INFORMATION ON INDICATIONS, SAFETY AND WARNINGS
For listing of Indications, Contraindications, Warnings, Precautions, and Potential Adverse Events, please refer to the Instructions For Use .